Biosimilar Red Tape Elimination Act

Referred to the House Committee on Energy and Commerce.

• Full Committee Markup of Twenty-Nine Pieces of Legislation
  Markup Jul 20, 2026 · 5:00 PM EDT · Energy and Commerce Committee

• S 1954 Biosimilar Red Tape Elimination Act

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Energy and Commerce Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
  for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS · Maryland · 3rd Quarter 2026 (July 1 - Sep 30)
• AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
  for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• COVINGTON & BURLING LLP
  for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• AMGEN, INC.
  for AMGEN INC · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• AVENUE SOLUTIONS
  for AMGEN, INC. · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• JOHNSON & JOHNSON SERVICES, INC.
  for JOHNSON & JOHNSON SERVICES INC · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

• SENATE
  68 filings
• HOUSE OF REPRESENTATIVES
  66 filings
• Centers For Medicare and Medicaid Services (CMS)
  39 filings
• Health & Human Services, Dept of (HHS)
  36 filings
• White House Office
  20 filings
• Commerce, Dept of (DOC)
  16 filings
• U.S. Trade Representative (USTR)
  16 filings
• Food & Drug Administration (FDA)
  13 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.